Earnings Scheduled For March 18, 2024
Portfolio Pulse from Benzinga Insights
Earnings reports for March 18, 2024, include a mix of expected profits and losses across various sectors. Notable companies like Embraer, Science Applications Intl, and StoneCo are anticipated to report profits, while System1, Exagen, and OneConnect Financial Tech project losses. The diversity in performance highlights the varied economic conditions impacting different industries.
March 18, 2024 | 9:57 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Embraer is estimated to report quarterly earnings at $0.53 per share on revenue of $2.00 billion, indicating strong performance.
Embraer's expected earnings suggest a strong quarter, likely to positively influence its stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Science Applications Intl is likely to report quarterly earnings at $1.43 per share on revenue of $1.64 billion, indicating a positive performance.
Science Applications Intl's anticipated earnings reflect a strong financial performance, potentially leading to a positive stock price movement.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
StoneCo is projected to report quarterly earnings at $0.30 per share on revenue of $685.73 million, suggesting a robust quarter.
StoneCo's expected earnings indicate a strong quarter, which is likely to have a favorable impact on its stock price in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
OneConnect Financial Tech is projected to report a quarterly loss at $1.62 per share on revenue of $142.69 million, indicating significant challenges.
The significant projected loss for OneConnect Financial Tech may lead to a negative reaction in its stock price, reflecting investor concerns.
CONFIDENCE 60
IMPORTANCE 55
RELEVANCE 65
NEGATIVE IMPACT
System1 is estimated to report a quarterly loss at $0.33 per share on revenue of $93.81 million, indicating challenges.
System1's projected quarterly loss may negatively affect its stock price in the short term due to perceived financial challenges.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
Exagen is likely to report a quarterly loss at $0.43 per share on revenue of $11.56 million, reflecting financial difficulties.
Exagen's anticipated quarterly loss could lead to a negative short-term impact on its stock price due to investor concerns over its financial health.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70